Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmaceutical companies advantages

Microorganisms are extremely versatile chemists. The wide variety of structures among the relatively few compounds discussed here is testimony to that. There are several theories to explain the evolutionary advantage conferred by the synthesis of secondary metabolites. (It often seems that they serve primarily to enrich pharmaceutical companies.) Until recently, the idea that they conferred a competitive advantage upon the producing organism seemed reasonable, since most of the products that had been detected had antibiotic activity. [Pg.71]

In recent years, developments in high-throughput screening inspired many pharmaceutical companies to focus and rely on combinatorial chemistry, especially massive parallel synthesis, to find new lead structures. The employed chemistry is often simple and the concept depends on sheer numbers for success. The main research areas were heterocyclic and peptide chemistry, and the resulting structures often lacked complexity and diversity, and most importantly the chance to utilize the evolutionary advantage of natural products with their privileged structures. [Pg.141]

ABET believes that the technology has applications in medical centers, veterinary schools, pharmaceutical companies, and state and federal governmental research and testing agencies. According to the developer, the WR process has the following advantages ... [Pg.342]

On the other hand many commercial successes are low-tech or even no-tech and can be profitable without any significant technical breakthroughs. For instance, in the food industry, typically only 0.3% of companies turnover is spent on R D activities, as compared with 10-15% by pharmaceutical companies. Large companies often have an advantage as they are capable of investing in multi-disciplinary research... [Pg.492]

Two different aspects have to be considered in the answer economic and scientific. An economic interest to have a variety of products in the market exists on the part of those pharmaceutical companies that have developed and marketed or are developing antipsychotics. Consequently, their advertising places the emphasis on the special features and advantages of individual medications, even though the differences between many products are not always very relevant clinically. Nevertheless, the differences that actually exist between products with regard to their pharmacokinetic and pharmacodynamic properties are of scientific interest, especially those related to the effects of atypical versus typical antipsychotics ... [Pg.6]


See other pages where Pharmaceutical companies advantages is mentioned: [Pg.58]    [Pg.47]    [Pg.30]    [Pg.154]    [Pg.428]    [Pg.586]    [Pg.303]    [Pg.9]    [Pg.17]    [Pg.66]    [Pg.169]    [Pg.97]    [Pg.421]    [Pg.6]    [Pg.89]    [Pg.133]    [Pg.134]    [Pg.156]    [Pg.248]    [Pg.263]    [Pg.267]    [Pg.302]    [Pg.75]    [Pg.14]    [Pg.106]    [Pg.490]    [Pg.576]    [Pg.639]    [Pg.246]    [Pg.211]    [Pg.259]    [Pg.358]    [Pg.803]    [Pg.8]    [Pg.60]    [Pg.62]    [Pg.95]    [Pg.101]    [Pg.105]    [Pg.58]    [Pg.166]    [Pg.443]    [Pg.133]    [Pg.63]    [Pg.27]   
See also in sourсe #XX -- [ Pg.189 , Pg.190 , Pg.191 ]




SEARCH



Pharmaceutical companies

Pharmaceuticals advantages

© 2024 chempedia.info